The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer

References

• Jiménez G, Guichet A, Ephrussi A, et al. Relief of gene repression by Torso RTK signaling: role of capicua in Drosophila terminal and dorsoventral patterning. Genes Dev. 2000;14:224–231. PMID: 10652276.
   PubMed Web of Science ®Google Scholar
• Jiménez G, Shvartsman SY, Paroush Z. The Capicua repressor – a general sensor of RTK signaling in development and disease. J Cell Sci. 2012;125:1383–1389. PMID: 22526417. doi:10.1242/jcs.092965.
   PubMed Web of Science ®Google Scholar
• Papagianni A, Forés M, Shao W, et al. Capicua controls Toll/IL-1 signaling targets independently of RTK regulation. Proc Natl Acad Sci USA. 2018;115:1807–1812. PMID: 29432195. doi:10.1073/pnas.1713930115.
   PubMed Web of Science ®Google Scholar
• Roch F, Jiménez G, Casanova J. EGFR signaling inhibits Capicua-dependent repression during specification of Drosophila wing veins. Development. 2002;129:993–1002. PMID: 11861482.
   PubMed Web of Science ®Google Scholar
• Astigarraga S, Grossman R, Díaz-Delfín J, et al. A MAPK docking site is critical for downregulation of Capicua by Torso and EGFR RTK signaling. EMBO J. 2007;26:668–677. PMID: 17255944. doi:10.1038/sj.emboj.7601532.
   PubMed Web of Science ®Google Scholar
• Tseng AS, Tapon N, Kanda H, et al. Capicua regulates cell proliferation downstream of the receptor tyrosine kinase/ras signaling pathway. Curr Biol. 2007;17:728–733. PMID: 17398096. doi:10.1016/j.cub.2007.03.023.
   PubMed Web of Science ®Google Scholar
• Lim B, Samper N, Lu H, et al. Kinetics of gene derepression by ERK signaling. Proc Natl Acad Sci USA. 2013;110:10330–10335. PMID: 23733957. doi:10.1073/pnas.1303635110.
   PubMed Web of Science ®Google Scholar
• Jin Y, Ha N, Forés M, et al. EGFR/Ras signaling controls Drosophila intestinal stem cell proliferation via Capicua-regulated genes. PLoS Genet. 2015;11:e1005634. PMID: 26683696. doi:10.1371/journal.pgen.1005634.
   PubMed Web of Science ®Google Scholar
• Grimm O, Sanchez Zini V, Kim Y, et al. Torso RTK controls Capicua degradation by changing its subcellular localization. Development. 2012;139:3962–3968. PMID: 23048183. doi:10.1242/dev.084327.
   PubMed Web of Science ®Google Scholar
• Herranz H, Hong X, Cohen SM. Mutual repression by bantam miRNA and Capicua links the EGFR/MAPK and Hippo pathways in growth control. Curr Biol. 2012;22:651–657. PMID: 22445297. doi:10.1016/j.cub.2012.02.050.
   PubMed Web of Science ®Google Scholar
• Pascual J, Jacobs J, Sansores-Garcia L, et al. Hippo reprograms the transcriptional response to Ras signaling. Dev Cell. 2017;42:667–680. PMID: 28950103. doi:10.1016/j.devcel.2017.08.013.
   PubMed Web of Science ®Google Scholar
• Ajuria L, Nieva C, Winkler C, et al. Capicua DNA-binding sites are general response elements for RTK signaling in Drosophila. Development. 2011;138:915–924. PMID: 21270056. doi:10.1242/dev.057729.
   PubMed Web of Science ®Google Scholar
• Samee MA, Lim B, Samper N, et al. A systematic ensemble approach to thermodynamic modeling of gene expression from sequence data. Cell Syst. 2015;1:396–407. PMID: 27136354. doi:10.1016/j.cels.2015.12.002.
   PubMed Web of Science ®Google Scholar
• Liang HL, Nien CY, Liu HY, et al. The zinc-finger protein Zelda is a key activator of the early zygotic genome in Drosophila. Nature. 2008;456:400–3. PMID: 18931655. doi:10.1038/nature07388.
   PubMed Web of Science ®Google Scholar
• Löhr U, Chung HR, Beller M, et al. Antagonistic action of Bicoid and the repressor Capicua determines the spatial limits of Drosophila head gene expression domains. Proc Natl Acad Sci USA. 2009;106:21695–21700. PMID: 19959668. doi:10.1073/pnas.0910225106.
   PubMed Web of Science ®Google Scholar
• Nolo R, Morrison CM, Tao C, et al. The bantam microRNA is a target of the hippo tumor-suppressor pathway. Curr Biol. 2006;16:1895–904. PMID: 16949821. doi:10.1016/j.cub.2006.08.057.
   PubMed Web of Science ®Google Scholar
• Oh H, Irvine KD. Cooperative regulation of growth by Yorkie and Mad through bantam. Dev Cell. 2011;20:109–22. PMID: 21238929. doi:10.1016/j.devcel.2010.12.002.
   PubMed Web of Science ®Google Scholar
• Yang L, Paul S, Trieu KG, et al. Minibrain and Wings apart control organ growth and tissue patterning through down-regulation of Capicua. Proc Natl Acad Sci USA. 2016;113:10583–10588. PMID: 27601662. doi:10.1073/pnas.1609417113.
   PubMed Web of Science ®Google Scholar
• Degoutin JL, Milton CC, Yu E, et al. Riquiqui and minibrain are regulators of the hippo pathway downstream of Dachsous. Nat Cell Biol. 2013;15:1176–85. PMID: 23955303. doi:10.1038/ncb2829.
   PubMed Web of Science ®Google Scholar
• Krivy K, Bradley-Gill MR, Moon NS. Capicua regulates proliferation and survival of RB-deficient cells in Drosophila. Biol Open. 2013;2:183–190. PMID: 23429853. doi:10.1242/bio.20123277.
   PubMed Web of Science ®Google Scholar
• Lee CJ, Chan WI, Cheung M, et al. CIC, a member of a novel subfamily of the HMG-box superfamily, is transiently expressed in developing granule neurons. Brain Res Mol Brain Res. 2002;106:151–156. PMID: 12393275. doi:10.1016/S0169-328X(02)00439-4.
   PubMedGoogle Scholar
• Lee Y, Fryer JD, Kang H, et al. ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization. Dev Cell. 2011;21:746–757. PMID: 22014525. doi:10.1016/j.devcel.2011.08.017.
   PubMed Web of Science ®Google Scholar
• Lam YC, Bowman AB, Jafar-Nejad P, et al. ATXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell. 2006;127:1335–1347. PMID: 17190598. doi:10.1016/j.cell.2006.11.038.
   PubMed Web of Science ®Google Scholar
• Forés M, Ajuria L, Samper N, et al. Origins of context-dependent gene repression by capicua. PLoS Genet. 2015;11:e1004902. PMID: 25569482. doi:10.1371/journal.pgen.1004902.
   PubMed Web of Science ®Google Scholar
• Kim E, Park S, Choi N, et al. Deficiency of Capicua disrupts bile acid homeostasis. Sci Rep. 2015;5:8272. PMID: 25653040. doi:10.1038/srep08272.
   PubMed Web of Science ®Google Scholar
• Kim E, Lu HC, Zoghbi HY, et al. Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein Ataxin-1 and Capicua. Genes Dev. 2013;27:590–5. PMID: 23512657. doi:10.1101/gad.212068.112.
   PubMed Web of Science ®Google Scholar
• Futran AS, Kyin S, Shvartsman SY, et al. Mapping the binding interface of ERK and transcriptional repressor Capicua using photocrosslinking. Proc Natl Acad Sci USA. 2015;112:8590–8595. PMID: 26124095. doi:10.1073/pnas.1501373112.
   PubMed Web of Science ®Google Scholar
• Kawamura-Saito M, Yamazaki Y, Kaneko K, et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet. 2006;15:2125–2137. PMID: 16717057. doi:10.1093/hmg/ddl136.
   PubMed Web of Science ®Google Scholar
• Forés M, Simón-Carrasco L, Ajuria L, et al. A new mode of DNA binding distinguishes Capicua from other HMG-box factors and explains its mutation patterns in cancer. PLoS Genet. 2017;13:e1006622. PMID: 28278156. doi:10.1371/journal.pgen.1006622.
   PubMed Web of Science ®Google Scholar
• Dissanayake K, Toth R, Blakey J, et al. ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicua. Biochem J. 2011;433:515–525. PMID: 21087211. doi:10.1042/BJ20101562.
   PubMed Web of Science ®Google Scholar
• Banfi S, Servadio A, Chung MY, et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet. 1994;7:513–520. PMID: 7951322. doi:10.1038/ng0894-513.
   PubMed Web of Science ®Google Scholar
• Crespo-Barreto J, Fryer JD, Shaw CA, et al. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis. PLoS Genet. 2010;6:e1001021. PMID: 20628574. doi:10.1371/journal.pgen.1001021.
   PubMed Web of Science ®Google Scholar
• Tsai CC, Kao HY, Mitzutani A, et al. Ataxin 1, a SCA1 neurodegereative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors. Proc Natl Acad Sci USA. 2004;101:4047–4052. PMID: 15016912. doi:10.1073/pnas.0400615101.
   PubMed Web of Science ®Google Scholar
• Fryer JD, Yu P, Mandel-Brehm C, et al. Exercise and genetic rescue of SCA1 via the transcriptional repressor Capicua. Science. 2011;334:690–693. PMID: 22053053. doi:10.1126/science.1212673.
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves CA, Rousseaux MW, Guerrero-Muñoz MJ, et al. A native interactor scaffolds and stabilizes ATAXIN-1 oligomers in SCA1. Elife. 2015;4:e07558. doi:10.7554/eLife.07558. PMID: 25988806.
   PubMed Web of Science ®Google Scholar
• Park J, Al-Ramahi I, Tan Q, et al. RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity and SCA1. Nature. 2013;498:325–331. PMID: 23719381. doi:10.1038/nature12204.
   PubMed Web of Science ®Google Scholar
• Simón-Carrasco L, Graña O, Salmón M, et al. Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma. Genes Dev. 2017;31:1456–1468. PMID: 28827401. doi:10.1101/gad.300244.117.
   PubMed Web of Science ®Google Scholar
• Tan Q, Brunetti L, Rousseaux MWC, et al. Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma. Proc Natl Acad Sci USA. 2018;115:E1511–E1519. PMID: 29382756. doi:10.1073/pnas.1716452115.
   PubMed Web of Science ®Google Scholar
• Lu HC, Tan Q, Rousseaux MW, et al. Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans. Nat Genet. 2017;49:527–536. PMID: 28288114. doi:10.1038/ng.3808.
   PubMed Web of Science ®Google Scholar
• Park S, Lee S, Lee CG, et al. Capicua deficiency induces autoimmunity and promotes follicular helper T cell differentiation via derepression of ETV5. Nat Commun. 2017;8:16037. PMID: 28855737. doi:10.1038/ncomms16037.
   PubMed Web of Science ®Google Scholar
• Kim E, Kim D, Lee JS, et al. Capicua suppresses hepatocellular carcinoma progression by controlling ETV4-MMP1 axis. Hepatology. 2017;Dec 18;doi:10.1002/hep.29738. PMID: 29251790. doi:10.1002/hep.29738.
   PubMedGoogle Scholar
• Yang R, Chen LH, Hansen LJ, et al. Cic loss promotes gliomagenesis via aberrant neural stem cell proliferation and differentiation. Cancer Res. 2017;doi:10.1158/0008-5472.CAN-17-1018. PMID: 28939681.
   PubMedGoogle Scholar
• Vissers LE, de Ligt J, Gilissen C, et al. A de novo paradigm for mental retardation. Nat Genet. 2010;42:1109–1112. PMID: 21076407. doi:10.1038/ng.712.
   PubMed Web of Science ®Google Scholar
• Athanasakis E, Licastro D, Faletra F, et al. Next generation sequencing in nonsyndromic intellectual disability: from a negative molecular karyotype to a possible causative mutation detection. Am J Med Genet A. 2014;164A:170–176. PMID: 24307393. doi:10.1002/ajmg.a.36274.
   PubMedGoogle Scholar
• Drosten M, Dhawahir A, Sum EY, et al. Genetic analysis of Ras signaling pathways in cell proliferation, migration and survival. EMBO J. 2010;29:1091–1104. PMID: 20150892. doi:10.1038/emboj.2010.7.
   PubMed Web of Science ®Google Scholar
• Drosten M, Sum EY, Lechuga CG, et al. Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway. Proc Natl Acad Sci USA. 2014;111:15155–15160. PMID: 25288756. doi:10.1073/pnas.1417549111.
   PubMed Web of Science ®Google Scholar
• Lechuga CG, Simón-Carrasco L, Jacob HK, et al. Genetic validation of cell proliferation via Ras-independent activation of the Raf/Mek/Erk pathway. Methods Mol Biol. 2017;1487:269–276. PMID: 27924574. doi:10.1007/978-1-4939-6424-6_20.
   PubMedGoogle Scholar
• Le Gallic L, Sgouras D, Beal G Jr, et al. Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation. Mol Cell Biol. 1999;19:4121–4133. PMID: 10330152. doi:10.1128/MCB.19.6.4121.
   PubMed Web of Science ®Google Scholar
• Maki K, Arai H, Waga K, et al. Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation. Mol Cell Biol. 2004;24:3227–3237. PMID: 15060146. doi:10.1128/MCB.24.8.3227-3237.2004.
   PubMed Web of Science ®Google Scholar
• Bettegowda C, Agrawal N, Jiao Y, et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science. 2011;333:1453–1455. PMID: 21817013. doi:10.1126/science.1210557.
   PubMed Web of Science ®Google Scholar
• Yip S, Butterfield YS, Morozova O, et al. Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers. J Pathol. 2012;226:7–16. PMID: 22072542. doi:10.1002/path.2995.
   PubMed Web of Science ®Google Scholar
• Killela PJ, Reitman ZJ, Jiao Y, et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA. 2013;110:6021–6026. PMID: 23530248. doi:10.1073/pnas.1303607110.
   PubMed Web of Science ®Google Scholar
• Dang L, White DW, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462:739–744. PMID: 19935646. doi:10.1038/nature08617.
   PubMed Web of Science ®Google Scholar
• Xu W, Yang H, Liu Y, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell. 2011;19:17–30. PMID: 21251613. doi:10.1016/j.ccr.2010.12.014.
   PubMed Web of Science ®Google Scholar
• Chittaranjan S, Chan S, Yang C, et al. Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity. Oncotarget. 2014;5:7960–7979. PMID: 25277207. doi:10.18632/oncotarget.2401.
   PubMedGoogle Scholar
• Suzuki H, Aoki K, Chiba K, et al. Mutational landscape and clonal architecture in grade II and grade III gliomas. Nat Genet. 2015;47:458–468. PMID: 25848751. doi:10.1038/ng.3273.
   PubMed Web of Science ®Google Scholar
• Aihara K, Mukasa A, Nagae G, et al. Genetic and epigenetic stability of oligodendrogliomas at recurrence. Acta Neuropathol Commun. 2017;5:18. PMID: 28270234. doi:10.1186/s40478-017-0422-z.
   PubMed Web of Science ®Google Scholar
• Gleize V, Alentorn A, Connen de Kérillis L, et al. CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas. Ann Neurol. 2015;78:355–374. PMID: 26017892. doi:10.1002/ana.24443.
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–404. PMID: 22588877. doi:10.1158/2159-8290.CD-12-0095.
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical prolfiles using cBioPortal. Sci Signal. 2013;6:l1. PMID: 23550210. doi:10.1126/scisignal.2004088.
   PubMed Web of Science ®Google Scholar
• Okimoto RA, Breitenbuecher F, Olivas VR, et al. Inactivation of Capicua drives cancer metastasis. Nat Genet. 2017;49:87–96. PMID: 27869830. doi:10.1038/ng.3728.
   PubMed Web of Science ®Google Scholar
• Okimoto RA, Bivona TG. Metastasis: From head to tail. Cell Cycle. 2017;16:487–488. PMID: 28055306. doi:10.1080/15384101.2016.1271636.
   PubMed Web of Science ®Google Scholar
• Seim I, Jeffery PL, Thomas PB, et al. Whole-genome sequence of the metastatic PC3 and LNCaP human prostate cancer cell lines. G3 (Bethesda). 2017;7:1731–1741. PMID: 28413162.
   PubMedGoogle Scholar
• Sturm D, Orr BA, Toprak UH, et al. New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell. 2016;164:1060–1072. PMID: 26919435. doi:10.1016/j.cell.2016.01.015.
   PubMed Web of Science ®Google Scholar
• Drosten M, Simón-Carrasco L, Hernández-Porras I, et al. H-Ras and K-Ras oncoproteins induce different tumor spectra when driven by the same regulatory sequences. Cancer Res. 2017;77:707–718. PMID: 27872088. doi:10.1158/0008-5472.CAN-16-2925.
   PubMed Web of Science ®Google Scholar
• Von Lintig FC, Huvar I, Law P, Diccianni MB, et al. Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia. Clin Cancer Res. 2000;6:1804–1810. PMID: 10815901.
   PubMed Web of Science ®Google Scholar
• Oshima K, Khiabanian H, da Silva-Almeida AC, et al. Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia. Proc Natl Acad Sci USA. 2016;113:11306–11311. PMID: 27655895. doi:10.1073/pnas.1608420113.
   PubMed Web of Science ®Google Scholar
• Dail M, Li Q, McDaniel A, et al. Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents. Proc Natl Acad Sci USA. 2010;107:5106–5111. PMID: 20194733. doi:10.1073/pnas.1001064107.
   PubMed Web of Science ®Google Scholar
• Wang B, Krall EB, Aguirre AJ, et al. ATXN1L, CIC, and ETS transcription factors modulate sensitivity to MAPK pathway inhibition. Cell Rep. 2017;18:1543–1557. PMID: 28178529. doi:10.1016/j.celrep.2017.01.031.
   PubMed Web of Science ®Google Scholar
• Liao S, Davoli T, Leng Y, et al. A genetic interaction analysis identifies cancer drivers that modify EGFR dependency. Genes Dev. 2017;31:184–196. PMID: 28167502. doi:10.1101/gad.291948.116.
   PubMed Web of Science ®Google Scholar
• Mizutani A, Wang L, Rajan H, et al. Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. EMBO J. 2005;24:3339–3351. PMID: 16121196. doi:10.1038/sj.emboj.7600785.
   PubMed Web of Science ®Google Scholar
• Thompson BJ, Cohen SM. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell. 2006;126:767–74. doi:10.1016/j.cell.2006.07.013.
   PubMed Web of Science ®Google Scholar